GAMIFANT® (emapalumab-lzsg) Mechanism of Disease \u0026 Mechanism of Action for Primary HLH

(8:24)

FDA Approval of Gamifant® (emapalumab-Iszg) for Primary HLH Treatment

(10:)

Gamifant: Starting Your Treatment

(5:49)

Primary HLH: Diagnosis and Treatment

(17:22)

Gamifant: Initiating Treatment

(11:17)

Gamifant: In Primary HLH

(6:15)

Real HLH Interview on Emapalumab Therapy

(26:17)

A Patient Case: Mack’s Primary HLH Journey

(8:38)

Gamifant: Investigating HLH Ep. 4

(53:41)

Emapalumab therapy interview with Dr. Bethany Verkamp

(6:40)

Primary HLH: Treatment Options

(5:27)

Emapalumab mode of action

(1:23)

Michael Jordan, MD, Differentiates HLH Treatment in Pediatric Patients Versus Adults with Emapalumab

(2:31)

Emapalumab for pediatric pHLH: pivotal study results

(11:43)

Primary HLH: An Overview

(6:21)

Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal-Updates from ACR Convergence 2024

(46:41)

Dr. Budd Discusses Paclitaxel Regimens in Breast Cancer

(1:9)

SOBI Overview at ASH: Data from Phase 2/3 Clinical Study of Emapalumab-lzsg in Primary HLH

(2:31)

Primary Haemophagocytic Lymphohistiocytosis: Overview and New Treatment Option

(5:13)